Clinical Trials

Breast Neoplasms, Breast Neoplasms, Male

NCT00513695 2019-08-07

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

68 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00971737 2019-04-24

Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast Cancer

63 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00425672 2018-12-05

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

15 enrolled 13 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00847171 2018-09-26

Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

20 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01394211 2018-07-26

Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer

2 enrolled 3 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01928186 2018-05-15

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Phase NA Completed

28 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00423917 2018-05-08

Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer

36 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01086605 2018-05-08

Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer

46 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01091454 2018-05-08

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

48 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT00617539 2018-04-20

Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases

30 enrolled 10 charts

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

NCT00834678 2018-04-17

Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

11 enrolled 16 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT01042535 2018-04-11

Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer

44 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00722072 2018-02-26

Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy

12 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00470548 2018-01-10

Abraxane and Alimta in Advanced Solid Tumors

Phase 1/2 Terminated

49 enrolled 10 charts

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Breast Neoplasms, Male

NCT00821964 2018-01-02

Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer

15 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00376805 2017-12-28

Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer

6 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00723294 2017-08-14

Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer

Phase 2 Unknown

99 enrolled 4 charts

Breast Neoplasms, Carcinoma, Ductal, Breast, Breast Neoplasms, Male

NCT00331552 2017-07-26

Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer

30 enrolled 13 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00003199 2017-07-12

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

50 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00343863 2017-07-11

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

Phase NA Completed

41 enrolled 12 charts

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male

NCT01105312 2017-06-27

Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer

28 enrolled 13 charts

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT01868503 2017-06-26

Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer

7 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00791037 2017-05-25

Vaccine Therapy in Treating Patients With Stage IV Breast Cancer

23 enrolled 9 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00482391 2017-05-12

Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer

95 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00662129 2017-04-17

Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer

50 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00176488 2017-03-23

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

31 enrolled 6 charts